Nuvalent (NUVL) Tax Provisions (2024 - 2026)

Nuvalent (NUVL) reported Tax Provisions of $168000.0 for Q1 2026, up 7.01% on a YoY basis from $157000.0 in Q1 2025, and up 1.2% quarter-over-quarter from $166000.0 in Q4 2025.

Nuvalent (NUVL) Tax Provisions (2024 - 2026) Analysis & Trends

Nuvalent has reported Tax Provisions for 3 years, with the latest figure at $168000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Tax Provisions rose 7.01% year-over-year to $168000.0; the trailing twelve-month figure through Mar 2026 stood at $611000.0 (up 13.57% YoY), and the FY2025 full-year result was $600000.0, down 21.47% from the prior year.
  • Tax Provisions for Q1 2026 stood at $168000.0, up from $166000.0 in the prior quarter.
  • The five-year high for Tax Provisions was $383000.0 in Q1 2024, with the low at $40000.0 in Q3 2024.
  • Historically, Tax Provisions has averaged $170222.2 across 3 years, with a median of $166000.0 in 2025.
  • The largest YoY upside for Tax Provisions was 230.0% in 2025 against a maximum downside of 59.01% in 2025.
  • Nuvalent's Tax Provisions stood at $171000.0 in 2024, then retreated by 2.92% to $166000.0 in 2025, then rose by 1.2% to $168000.0 in 2026.
  • The last three Tax Provisions figures came in at $168000.0 (Q1 2026), $166000.0 (Q4 2025), and $132000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -11.20 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -859,000.00
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 216,000.00
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 221.50 Mn
9 Abivax 95.45 Bn 95.45 Bn - -
10 Nuvalent 9.69 Bn 9.69 Bn - 168,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 168,000.00
Dec 31, 2025 166,000.00
Sep 30, 2025 132,000.00
Jun 30, 2025 145,000.00
Mar 31, 2025 157,000.00
Dec 31, 2024 171,000.00
Sep 30, 2024 40,000.00
Jun 30, 2024 170,000.00
Mar 31, 2024 383,000.00